Back | Next |
home / stock / exel / exel message board
Subject | By | Source | When |
---|---|---|---|
Could be a better play here than acad, | harry crumb | investorshub | 06/19/2020 5:28:55 AM |
When cabo an cobi move to the next | harry crumb | investorshub | 06/19/2020 5:27:28 AM |
Mr. Crumb what is the next catalyst for | girlfriend | investorshub | 06/18/2020 1:04:23 PM |
Might be a sell at 30+ here, will | harry crumb | investorshub | 05/18/2020 1:58:28 PM |
whytestocks: $EXEL great article | whytestocks | investorshangout | 05/15/2020 7:10:45 PM |
Told everyone 2 yrs ago to hold an | harry crumb | investorshub | 04/27/2020 9:16:46 PM |
Going to $50!!! | vinmantoo | investorshub | 04/20/2020 11:50:00 PM |
Going to $50!!! | sorkin | investorshub | 04/20/2020 4:55:28 PM |
I see Motley Fool recommending this stock, but | fung_derf | investorshub | 02/11/2020 4:22:05 PM |
An opportunity to add is here folks. $$$$ | harry crumb | investorshub | 09/27/2019 5:36:17 PM |
Going to buy more. Longvan strong for buyout | harry crumb | investorshub | 08/05/2019 12:56:04 AM |
whytestocks: $EXEL News Article - Exelixis Updates Phase 1b COSMIC-021 Trial of Cabozantinib in Comb | whytestocks | investorshangout | 07/15/2019 3:50:41 PM |
Buy these up people, buyout coming! | harry crumb | investorshub | 05/20/2019 11:42:39 PM |
All that means is this company will be | harry crumb | investorshub | 04/18/2019 12:04:12 AM |
Approval of the proposal of Exelixis Board of | tpg | investorshub | 04/13/2019 5:21:33 PM |
whytestocks: $EXEL News Article - Exelixis to Present at the 18th Annual Needham Healthcare Conferen | whytestocks | investorshangout | 04/05/2019 8:50:41 PM |
Big money made here! Holding a core in | harry crumb | investorshub | 01/25/2019 11:53:01 PM |
Congrats to all who bought more or consolidated | harry crumb | investorshub | 01/24/2019 1:04:25 PM |
They approved 5 or 6 on the 10th...and | rabbit67 | investorshub | 01/13/2019 5:15:45 PM |
Be careful. Powers that be take it lower | robtewms | investorshub | 11/11/2018 5:54:13 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-05-01 02:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-01 00:00:13 ET Image source: The Motley Fool. Exelixis (NASDAQ: EXEL) Q1 2024 Earnings Call Apr 30, 2024 , 5:00 p.m. ET Operator Continue reading For further details see: Exelixis (EXEL) Q1 2024 Earnings Call Transcript
- Total Revenues of $425 million, Cabozantinib Franchise U.S. Net Product Revenues of $379 million - - Restructuring Expenses of $32.8 million Recorded - - GAAP Diluted EPS of $0.12, Non-GAAP Diluted EPS of $0.17 - - Conference Call and Webcast Today at 5:00 PM...